Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Guido Neels Insider Profile
4 Followers
Guido Neels, Director at AxoGen, holds 2.59K shares in AxoGen (Ticker: AXGN), holds 43.20K shares in Endologix (Ticker: ELGXQ), holds 0.00 shares in Entellus Medical (Ticker: ENTL).
Profitable Transactions
3 out of 9 Profitable Transactions
Average Return
+4.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Stock:
Endologix
(ELGXQ)
(ELGXQ)
Rating:Informative Buy
Date:Mar 02, 2011 - Mar 02, 2012
Return:+119.60%
The most profitable trade made by Guido Neels
Guido Neels's Trading History
AxoGen
Sep 08, 2020
Director
Uninformative Buy
30.44K
$37.26K
Endologix
Apr 03, 2019
―
Informative Buy
149.99K
$820.80
Entellus Medical
Mar 01, 2018
―
Uninformative Sell
420.00K
$0.00
Lemaitre Vascular
―
Director
―
$111.02K
List of latest transactions for each holding click on a transaction to see Guido Neels's performance on stock
You May Also Like
Guido Neels insider profile FAQ
What is the percentage of profitable transactions made by Guido Neels?
The percentage of profitable transactions made by Guido Neels is 33%.
What is the average return per transaction made by Guido Neels?
The average return per transaction made by Guido Neels is 4.80%.
What stocks does Guido Neels hold?
Guido Neels holds: AXGN, ELGXQ, ENTL, LMAT stocks.
What was Guido Neels’s latest transaction?
Guido Neels latest transaction was an Uninformative Buy of $30.44K.
What was Guido Neels's most profitable transaction?
Guido Neels’s most profitable transaction was an Informative Buy of ELGXQ stock on March 2, 2011. The return on the trade was 119.60%.
What is Guido Neels's role in AxoGen?
Guido Neels's role in AxoGen is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.